PMCID: PMC4075452 Griffith O, Meister A (1979) Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine)
Its remarkable weight loss effects in clinical trials led to separate FDA approval for chronic weight management in adults with obesity or overweight with weight-related health conditions (brand name Wegovy)
For many, tirzepatide is more than a treatment
RELATED: New GLP-1 drugs could suppress desire for more than just food, study suggests For patients with a body mass index (BMI) of over 35, the heaviest people in the trial, the weight loss was even higher: They lost an average of 85 pounds, or 30.3% of their body weight, after two years
This was primarily due to the limited number of RCTs in the predefined age group (1865 years)
Best high-fiber foods for GLP-1: Oats and barley rich in beta-glucan, a soluble fiber with strong evidence for improving glycemic response and supporting gut hormone release